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Abstract 
Objective: Diabetes is a global problem with devastating human, social and economic impact. Anti-diabetic medica-
tions play a major role in the glycemic control of patients with diabetes. However, inadequate adherence compro-
mises safety and treatment effectiveness, leading to increased mortality and morbidity. The aim of this study was to 
assess adherence to anti-diabetic medications and associated factors among patient with diabetes mellitus receiving 
care at Zewditu Memorial Hospital.
Results: Among the total of 146 diabetic patients (mean age 46.5 ± 14.7), the level of adherence to anti diabetic 
medication was 54.8% (80) whilst 45.2% (66) of the participants were non adherent. Multiple logistic regression 
showed that knowledge of medication (AOR = 4.905, 95% CI 1.64–14.62, medication availability (AOR = 0.175, 95% CI 
0.031–0.987) and education level (AOR = 13.65, 95% CI 1.45–128.456) were reasons for non-adherence.
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Introduction
Diabetes mellitus (DM) is probably one of the oldest dis-
eases known to man. It is defined as a “metabolic disor-
der caused by different factors characterized by a chronic 
high level of blood sugar with disturbances to carbohy-
drate, fat, and protein metabolism resulting from defects 
in insulin secretion, insulin action, or both. It is a com-
plex, chronic diseases requiring continuous medical care 
with multifactorial risk-reduction strategies beyond gly-
cemic control [1, 2].
The 2014 report stated that the global prevalence of 
diabetes among adults was 422 million, compared to 108 
million in 1980. This prevalence is nearly doubled since 
1980, rising from 4.7 to 8.5% in the adult population. By 
2030 this would have risen to 552 million [3, 4].
According to IDF 2003, diabetes is a global problem 
with devastating human, social and economic impact. 
Globally DM is the fifth leading cause of death by disease 
[5]. Every 7 s, diabetes causes the death of an individual 
worldwide, and in 2014 alone, 4.9 million deaths were 
attributed to diabetes with 80% of deaths related to dia-
betes reported from low- and middle-income countries 
[6]. According to WHO, diabetes was once considered a 
rare disease in sub-Saharan Africa. But in 2010, over 12 
million people in sub-Saharan Africa are estimated to 
have diabetes, and 330,000 people died from diabetes-
related conditions. Over the next 20 years, it is predicted 
that sub-Saharan Africa will have the highest growth 
in the number of people with diabetes of any region in 
the world—the 2010 estimated number is predicted to 
almost double in 20 years, reaching 23.9 million by 2030 
[7].
Ethiopia is estimated to have around 1.5 million people 
with diabetes. According to WHO data published in 2011 
DM dates in Ethiopia reached 21,550 or 2.62% of total 
deaths. The age adjusted death rate is 61.96 per 100,000 
of population ranks Ethiopia number 28 in the world and 
it is the 7th leading cause of death in Ethiopia [8].
A latest WHO report indicates that because the 
magnitude of non-adherence and the scope of its 
sequelae are so alarming, more health benefits 
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worldwide could be achieved by improving adher-
ence to available medications than by developing new 
treatment approaches. Studies revealed that compli-
ance to chronic medications in high income countries 
is 50%. In low income countries, the prevalence is 
even lower [9]. Poor compliance complicates the chal-
lenges of improving health in developing countries, 
and leads to waste and underutilization of already 
limited resources. Compliance studies are peculiar to 
every community and culture.
Adherence to medication is influenced by several fac-
tors such as lack of information, complexity of regimen, 
concomitant disease, and perceptions of benefit, side 
effects, medication cost, long duration and emotional 
wellbeing. Personality and cultural factors may influence 
adherence-compliance rates. Institutional factors such as 
the availability of medication at the hospital pharmacy, 
cost of medications, prescription patterns and accessi-
bility also affects adherence. Again the personal beliefs, 
knowledge on disease and medication, forgetfulness and 
financial burden also reduce adherence level. These fac-
tors are interrelated.
This study was aimed to assess level of adherence and 
identify factors that are particular to diabetic patients 
who receive care at Zewditu Memorial Hospital.
Main text
Methods
Study area and period
Prospective cross sectional study was conducted at 
chronic follow up unit of Zewditu Memorial Hospital. It 
is a general hospital in central Addis Ababa. The hospital 
deals also with palliative care, HIV counseling and test-
ing, and post-exposure prophylaxis (PEP) service. There 
are different clinics for follow-up of patients with chronic 
illness at the hospital. The study was conducted from 
February 20, 2017 to April 20, 2017.
Study participants and sample size determination
The study participants were all patients with diabe-
tes, aged at least 18  years, attending the diabetic clinic, 
which have been on anti-diabetic medication for greater 
than 6  months and gave informed consent to partici-
pate in the study. We excluded those who were very ill 
and those who were newly diagnosed with diabetes and 
on medication for less than 6  month from the study. A 
total of 146 participants were included by using single 
proportion formula and using p value of 0.89 from previ-
ous study and correction formula. The first patient was 
selected randomly and every 7th patient was included in 
the study. The dependent variable was adherence to anti 
diabetic medication.
Data collection procedures
Trained data collectors used pretested structured ques-
tionnaires to collect information on: patient demograph-
ics and variables used to assess patient adherence. And 
the data was cleared and checked every day for complete-
ness and consistency. The level of adherence assessment 
was measured by Morisky Medication Adherence Scale-8 
(MMAS-8).
Operational definitions
Adherence The extent to which a person’s behavior—
taking medication, following a diet, and/or executing 
lifestyle changes—corresponds with agreed recommen-
dations from a health care provider.
Adherent Patients who score 0 based on Morisky Medi-
cation Adherence Scale-8 (MMAS-8).
Non adherent Patients who score 1–8 based on Morisky 
Medication Adherence Scale-8 (MMAS-8).
Data management and analysis
The collected data were sorted, coded and entered into 
SPSS version 20 software for analysis. Descriptive statics 
was generated to summarize patient socio-demographic 
data; bivariate analysis was implemented to identify asso-
ciated factors. The crude odds ratio (COR), adjusted odds 
ratio (AOR) and 95% confidence interval (CI) were per-
formed to determine factors associated with anti-diabetic 
medications adherence and a p value of 0.05 or less was 
considered statistically significant.
Ethical consideration
Approval request paper cleared by ethical review commit-
tee from Addis Ababa University, College of health science, 
and school of pharmacy was submitted to Zewditu Memo-
rial Hospital to undertake the study. Written informed 
consent was obtained from study participants. Confidenti-
ality was maintained throughout the study process.
Results
Socio‑demographic characteristics of participants
A total of 146 diabetics aged 18–79 were recruited. All 
the participants had been on diabetic medication for 
6  months and above. The mean age of the participant 
was 46.5 years (± 14.6) with a range of (18–79 years). The 
majority of the participants were above 50 years. About 
23.3% (34) of the participants aged 51–60  years and 
17.8% (26/146) were older than 60 years. Female partici-
pants formed the majority.
There were 54.1% (79) females and 45.9% (67) males. 
Most of participants were married. The married par-
ticipants were 69.2% (101). For educational level, 34.9% 
(51) of the participant reported primary education 
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as their highest form of education. However, 223.3% 
(34) reported that they have had no formal education. 
Sixty-five (44.5%) participants were unemployed and 44 
(30.1%) were self-employed. Table 1 shows socio demo-
graphic characteristics of the participant.
Clinical characteristics of participants
Type 2 diabetics the commonest type of diabetics, 54% 
(80) participant had been diagnosed with type 2 diabet-
ics. However 25.3% (37) of the participants did not know 
type of diabetics. The mean number of medication pre-
scribed was 1.51 (± 0.816).
Institutional factors
More than 20% (35) of the respondents did not have all 
their diabetic medication available at the hospital phar-
macy. About 71.2% (104) reported that all their diabetic 
medication was covered by health insurance. Majority of 
the participant, 97.3% (142) reported that there was not 
any difficulty in getting their prescribed medication.
Regarding the service rendered, a larger proportion 
74.7% (110) of the participants reported that they were 
satisfied with it.
Participants knowledge of diabetes and medication
About 96.6% (141) reported they knew the name of their 
medication. However 93.8% (137) reported that they do 
not know any side effect of their diabetic medication. 
Majority of the participants had knowledge on diabetes 
mellitus, types, and sign of hypoglycemia and cause co-
morbid disease. However 10.3% (15) reported that dia-
betics can be cured (Fig. 1).
Determining the level of adherence
The level of adherence was assessed using eight item-
Morisky Medication Adherence Scale (MMAS-8). Partic-
ipants who had score of 0 were classified to adherent. The 
minimum score was 0 and the maximum score 4. Based 
on this classification 54.8% (80) of the participants were 
adherent whilst 45.2% (66) of the participants were non 
adherent.
Table 1 Socio-demographic characteristics of patient 
with diabetes mellitus attending diabetic clinic 
of Zewuditu Memorial Hospital
Variable Frequency Percent
Sex
 Male 67 45.9
 Female 79 54.1
Age
 18–30 25 17.1
 31–40 31 21.2
 41–50 30 20.5
 51–60 34 23.3
 > 60 26 17.8
Religion
 Orthodox 58 29.5
 Muslim 43 39.7
 Protestant 26 17.8
 Catholic 19 13.0
Ethnicity
 Amhara 57 39.0
 Oromo 41 28.1
 Tigre 22 15.1
 Other 26 17.8
Marital status
 Single 23 15.8
 Married 101 69.2
 Divorced 11 7.5
 Widowed 11 7.5
Educational level
 None 34 23.3
 Primary level 51 34.9
 Secondary level 43 29.5
 Tertiary level 18 12.3
Employment
 Unemployment 65 44.5
 Self employed 44 30.1
 Government 18 12.3
 Private 19 13.0
Monthly income in birr
 Low income (< 1000) 77 52.7
 Middle income (1001–2000) 33 22.6
 High income (2001–3000) 26 17.8





















Fig. 1 Distribution of participants on knowledge of diabetics and 
medication
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Factor affecting adherence
On bivariate analysis Medication availability, complexity 
of regimen, satisfaction and Education level were found 
to be significantly associated. On the other hand, multi-
ple logistic regression showed that knowledge of medi-
cation (AOR  =  4.905, 95% CI 1.64–14.62, medication 
availability (AOR = 0.175, 95% CI 0.031–0.987) and Edu-
cation level (AOR =  13.65, 95% CI 1.45–128.456) were 
reasons for non-adherence (Table 2).
Discussion
Currently, there is no single measure accepted as the 
gold standard to measure medication adherence since all 
commonly employed methods have drawbacks. In this 
study, from the available methods, a self-reported 8-item 
Morisky Medication Adherence Scale was used to assess 
medication non-adherence.
A systematic review on the adherence to medication 
among diabetic patients showed that the average compli-
ance to the oral hypoglycemic agents ranged from 36 to 
93% [10].
The magnitude of adherence level in this study was 
54.8%. In contrast to this finding, two studies in Ethiopia 
showed that the patients self-reported adherence rate to 
anti-diabetic medication was 72.2 and 68.8% [11, 12]. The 
difference may be attributed to, methodological varia-
tions and ways of measurement for adherence level.
Health care providers should be cognizant of knowl-
edge of patients on diabetes and how this may affect 
long-term efforts to successful management of diabetes 
mellitus. Emphasis on awareness creation about diabetes 
and its management is important to achieve positive dia-
betes outcomes. It was revealed in this study that patients 
who had no knowledge about diabetes were five times 
more likely to be non-adherent as compared to patients 
who had knowledge on diabetes. Other studies are also 
consistent with this finding.
Regarding educational level, it was found to be sig-
nificantly associated with the level of adherence to the 
treatment regimen. From different studies education 
has been identified as major socioeconomic determi-
nant of adherence to anti-diabetic medication. Low 
educational level has been associated with higher 
rates of non-adherence. This was supported by previ-
ous researches done in UAE [13]. Being illiterate makes 
learning more difficult; as diabetes drug therapy gets 
more complex, patients are required to have more com-
plex cognitive skills to be able to understand the pre-
scribed drug therapy and to adhere to treatment for 
good glucose control.
Availability of medications was one of the variables 
that found to be significantly associated with the adher-
ence status of the respondents. Findings of this study 
collaborated with other studies indicated an associa-
tion between medication adherence and medication 
availability [11, 13]. Unavailability of medications in the 
health institution has negative impact on patient adher-
ence, especially when it is accompanied by low eco-
nomic status. Because the patient cannot afford to bay 
medication from the private sectors, where medications 
are usually costly.
Concerning institutional factors, number of medi-
cation prescribed was independently associated with 
non-adherence. Participants who had complex regi-
men were more likely to have poor adherence. This 
finding is similar to study done in Jimma University 
Specialized Hospital [14]. This can be explained by 
the perception that participants who had more medi-
cations perceived themselves as severely ill and hope 
less to cure from chronic disease. Another indepen-
dently associated factor was patient satisfaction. This 
indicates that patients satisfied by service rendered in 
the hospital were adherent to their prescribed medica-
tion. Better relationship between health professionals 
and clients improve satisfaction. Findings from a study 
in Nigeria found an association between poor patient 
provider communication, lack of trust in the provider 
and adherence [15, 16].
Table 2 Factors affecting medication adherence of patients attending Zewuditu Memorial Hospital
p value of 0.05 or less was considered statistically significant (in italics)
Variable COR [95% CI] AOR [95% CI] p value
Knowledge of medication 0.179 (0.028–1.156) 4.905 (1.64–14.62) 0.004
Medication availability 0.011 (0.001–0.086) 0.175 (0.031–0.987) 0.048
Satisfaction 0.012 (0.002–0.971) 1.78 (0.518–6.128) 0.36
Perception about treatment outcome 2.089 (0.525–8.315) 1.955 (0.453–8.44) 0.369
Side effect knowledge 0.475 (0.109–2.068) 0.355 (0.064–1.956) 0.234
Complexity of regiment 31.952 (9.12–11.84) 2.822 (0.786–10.23) 0.112
Length of treatment 1.545 (0.165–14.47) 0.534 (.054–4.992) 0.465
Education level 0.027 (0.003–0.218) 13.65 (1.45–128.456 0.022
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Conclusion
In general, level of adherence to prescribed medica-
tions was poor among diabetic patients in diabetic clinic 
of ZMH. Knowledge of medication, medication avail-
ability and education level were found to be factors con-
tributory for medication non-adherence, all of which are 
modifiable factors. A lot should be done to maximize the 
medication adherence of these patients so that they can 
recognize the full importance of prescribed therapies.
Limitation
The study is single centered and it may limit its 
generalizability.
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